Based on data from the CDC, since 1999, there have been nearly one million overdose-related deaths. In 2020, the United States reported 91,799 overdose deaths, a 31% increase from the previous year....
Like any industry, recalls in the pharmaceutical industry are complex and expensive. However, as an added concern, pharmaceutical recalls have the potential to alter short and long-term health outcomes. Understanding the recall process for...
As the COVID pandemic has progressed, the healthcare industry has seen the virus and the state of the pandemic evolve. Equipped with the available vaccines and treatments, providers and other...
In recent months, patients, parents, and providers have become increasingly aware of the rise in viral infection rates. With the tripledemic — including COVID-19, respiratory syncytial virus...
Biosimilars, biologic products similar to brand-name biologics, are praised as a less expensive alternative for patients with chronic diseases requiring biologics. Many providers and healthcare experts...
As more and more providers warn against the tripledemic — including RSV, COVID, and influenza — it is crucial to understand the projections and impacts of these cases. Additionally, an in-depth understanding of the tools and...
The COVID-19 pandemic took the world by storm when it began in January 2020. Densely populated cities took a brutal hit with more significant percentages of infection, hospitalization, and death due to...
While less than ideal, the progression of the COVID-19 pandemic has presented public health officials with data to analyze on vaccine uptake. In a recent research letter published in JAMA Network Open,...
As with any vaccine, the COVID-19 vaccine led to some common side effects. However, the severity of these side effects varies by individual. In a recent study published in JAMA Network Open,...
Gonorrhea is one of the most common bacterial infections and is the third most common sexually transmitted infection (STI) in the United States. In an effort to mitigate disease spread, the NIH’s...
Although the development of antibiotics was a significant revolution in medicine, antibiotic education has become increasingly important as the rates of antibiotic-resistant bacteria have risen. As a result, providers are encouraged to...
On August 31, 2022, the FDA approved Moderna and Pfizer Bivalent COVID boosters to replace the previously available monovalent boosters. Since then, the CDC and other public health organizations have...
Throughout the COVID-19 pandemic, researchers and clinicians have worked tirelessly to develop new antiviral therapies to prevent, treat, and minimize the effects of the SARS-CoV-2 viral infection....
Antimicrobial stewardship is a plan to improve antibiotic use and prescription. Many organizations, such as Children's Hospital Colorado, are working to enhance antimicrobial stewardship practices. Michael Bozzella, DO, infectious...
As new COVID boosters are approved and distributed, understanding how they affect pregnant and lactating individuals will impact public health policies, educational efforts, and provider distribution....
Glucocorticoids are widely prescribed for those struggling with autoimmune and neurological conditions and are considered one of the most prescribed drugs. In a study published in BMJ Open, researchers...
As the COVID pandemic progresses and new variants appear, clinicians and public health professionals have been concerned about the level of vaccine protection for new variants and subvariants. To...
Ebola virus disease (EVD) is a potentially fatal disease caused by infection with ebolavirus. This WHO statement regards EVD caused by the Zaire ebolavirus. Following a review of many randomized...
As the COVID pandemic progresses and infection rates fluctuate, public health officials and organizations seek to provide more options to protect against illness. On August 19, Novavax announced that...
Starting in the 1900s, the opioid epidemic has been a determent to public health in the United States. Recent data and discoveries have named participants in the pharmaceutical industry as major...
